Vaxxa AB (XSAT:VAXXA) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:VAXXA Vaxxa AB XSAT:VAXXA
17 GF Score
Price kr0.42
GF Value kr0.75
Valuation Significantly Undervalued
View Full Analysis

What is Vaxxa AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Vaxxa AB Valuation Rank Related Terms

XSAT:VAXXA
17GF Score
Vaxxa AB XSAT:VAXXA
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vaxxa AB (XSAT:VAXXA) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of kr0.42 is trading 44.4% below its estimated GF Value™ of kr0.75. GuruFocus considers Vaxxa AB to be Significantly Undervalued.

Key valuation signals for XSAT:VAXXA:

  • Valuation Rank:
  • GF Value™: kr0.75 vs. price of kr0.42 (44.4% below fair value)
  • GF Score™: 17/100

No single metric tells the full story. See the XSAT:VAXXA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaxxa AB Business Description

Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
17GF Score

Get the complete analysis for XSAT:VAXXA

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.42
Price
kr0.75
GF Value